TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 157 participants.

Also called NCT05486832

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 157 participants (enrolled count) (from the registry)
Sponsor
Cardiovalve Ltd. (from the registry)
Registry
  • NCT NCT05486832
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05486832. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-09 (actual); primary completion 2026-03-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System
Acronym
TARGET
Condition
Tricuspid Regurgitation
Intervention (Device)
Cardiovalve TR valve replacement System
Lead sponsor
Cardiovalve Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05486832
Content hash
e030b9a7603dfdc5f1c819921d4c39fcd3884036b7984043c60e256c3045727d